Menu
Menu
treatments require
breakthrough strategies
treatments require
breakthrough strategies
treatments require
breakthrough strategies
Alkemi simplifies access with customized, step-by-step Breakthrough Blueprints that get Breakthrough treatments out of bottlenecks and into the hands of patients.
Alkemi simplifies access with customized, step-by-step Breakthrough Blueprints that get Breakthrough treatments out of bottlenecks and into the hands of patients.
Alkemi simplifies access with customized, step-by-step Breakthrough Blueprints that get Breakthrough treatments out of bottlenecks and into the hands of patients.
Market Access wasn't built
for Breakthroughs
Traditional market access strategies assume
you have years to execute, not months.
Traditional market access strategies assume you have years to execute, not months.
That's why we don't just deliver strategies - we
build Breakthrough Blueprints: step-by-step plans
with clear actions, not vague recommendations.
That's why we don't just deliver strategies - we build Breakthrough Blueprints:
step-by-step plans with clear actions, not vague recommendations.
Then, we partner with you to implement.
Now, you can launch into a market
that's primed for your new treatment.
Our Approach
How we launch Breakthroughs
Our signature methodology that turns access into adoption - fast.
Our signature methodology that turns access into adoption - fast.
step 01 // Design
The Market Map
See the whole field.
Plan the right moves.
We go below the surface and get clear on the market forces at play and the strategic direction required for your launch.
step 02 // Develop
The High-Impact Hitlist
Outcomes,
not output.
Outcomes, not output.
We ruthlessly eliminate the strategies & deliverables that are not essential so we can maximize the impact of those that are.
step 03 // Deploy
The Market Shaping Manual
Beyond recommendations.
Into implementation.
Most firms just tell you what to do. We help do it.
We design & execute step-by-step plans so you can get your stakeholders bought-in and your treatment rolled out.
Most firms just tell you what to do.
We help do it.
We design & execute step-by-step plans so you can get your stakeholders bought-in and your treatment rolled out.
CASE STUDIES
Oncology Treatment
Unrestricted patient access & full payer coverage granted in 7 days
(instead of the usual 6-9 months)
Helping boost company revenue by 140% and share price by 90% within 12 months.
Access Achieved, Fast
Optimal Payer Coverage
Total Reimbursement
Oncology Treatment
Unrestricted patient access & full payer coverage granted in 7 days
(instead of the usual 6-9 months)
Helping boost company revenue by 140% and share price by 90% within 12 months.
CASE STUDIES
Access Achieved, Fast
Optimal Payer Coverage
Total Reimbursement
Oncology Treatment
Unrestricted patient access & full payer coverage granted in 7 days
(instead of the usual 6-9 months)
Helping boost company revenue by 140% and share price by 90% within 12 months.
CASE STUDIES
Access Achieved, Fast
Optimal Payer Coverage
Total Reimbursement
CASE STUDIES
Oncology Treatment
Unrestricted patient access & full payer coverage granted in 7 days
(instead of the usual 6-9 months)
Helping boost company revenue by 140% and share price by 90% within 12 months.
Access Achieved, Fast
Optimal Payer Coverage
Total Reimbursement
About Alkemi
The Architects of Access
When time isn't on
your side, we are.
From kicking-off the first strategy session to clearing the final access hurdle, our senior experts are involved in every step - working in collaboration, not isolation.
The Alkemi team includes
Associates
12
PhD
3
MPH
3
MS
5
“The best work I’ve ever seen...
I wish I knew you at my last job.”
“The best work I’ve ever seen... I wish I knew you at my last job.”
“The best work I’ve ever seen...
I wish I knew you at my last job.”
“The best work I’ve ever seen...
I wish I knew you at my last job.”
Medical Review Board Lead
Rare Disease Oncology Biotech (Breakthrough)
Medical Review Board Lead
Rare Disease Oncology Biotech (Breakthrough)
Medical Review Board Lead
Rare Disease Oncology Biotech (Breakthrough)
Medical Review Board Lead
Rare Disease Oncology Biotech (Breakthrough)
“Great feedback continues on the ‘buzz’ … this is from president of intl…thank you to your entire team! Keep up the great work!!”
Vice President, HEOR
Rare Disease Oncology (Breakthrough)“In a record 3.5 days, guidelines have been updated to include [treatment]. Woohoo!!”
Vice President, HEOR
Rare Disease Oncology (Breakthrough)“They helped us identify our evidence gaps and develop a solid communication tool aligned with stakeholder needs. And they’re fun to work with!”
VP Strategy & Market Access Innovative Medical Device (Breakthrough)
“I wanted to reach out and tell you that the SLR publication is getting GREAT reception from senior BU leadership across the company. Thank you again for your and Alkemi’s support on this project!”
Associate Director Major Medical Device Company
“Excellent work! Alkemi was prepared with the details, holistic with the assessments, and strategic in the approach. I would not hesitate to use them again.”
Head of Medical Affairs Rare Disease Immunology Biotech (Breakthrough)
“Their strategic insights and support were essential – they have a knack for communicating differentiated value.”
Chief Commercial Officer Rare Degenerative Neuromuscular Biotech (Breakthrough)
“Just wanted to send an immediate thank you for the excellent training session today. It was very well received by all of us. What an amazing way to (almost) end the week! Thank you again.”
VP Market Access & Reimbursement Major Medical Technology Company
“Great feedback continues on the ‘buzz’ … this is from president of intl…thank you to your entire team! Keep up the great work!!”
Vice President, HEOR
Rare Disease Oncology (Breakthrough)“In a record 3.5 days, guidelines have been updated to include [treatment]. Woohoo!!”
Vice President, HEOR
Rare Disease Oncology (Breakthrough)“They helped us identify our evidence gaps and develop a solid communication tool aligned with stakeholder needs. And they’re fun to work with!”
VP Strategy & Market Access Innovative Medical Device (Breakthrough)
“I wanted to reach out and tell you that the SLR publication is getting GREAT reception from senior BU leadership across the company. Thank you again for your and Alkemi’s support on this project!”
Associate Director Major Medical Device Company
“Excellent work! Alkemi was prepared with the details, holistic with the assessments, and strategic in the approach. I would not hesitate to use them again.”
Head of Medical Affairs Rare Disease Immunology Biotech (Breakthrough)
“Their strategic insights and support were essential – they have a knack for communicating differentiated value.”
Chief Commercial Officer Rare Degenerative Neuromuscular Biotech (Breakthrough)
“Just wanted to send an immediate thank you for the excellent training session today. It was very well received by all of us. What an amazing way to (almost) end the week! Thank you again.”
VP Market Access & Reimbursement Major Medical Technology Company
“Great feedback continues on the ‘buzz’ … this is from president of intl…thank you to your entire team! Keep up the great work!!”
Vice President, HEOR
Rare Disease Oncology (Breakthrough)“In a record 3.5 days, guidelines have been updated to include [treatment]. Woohoo!!”
Vice President, HEOR
Rare Disease Oncology (Breakthrough)“They helped us identify our evidence gaps and develop a solid communication tool aligned with stakeholder needs. And they’re fun to work with!”
VP Strategy & Market Access
Innovative Medical Device (Breakthrough)
“I wanted to reach out and tell you that the SLR publication is getting GREAT reception from senior BU leadership across the company. Thank you again for your and Alkemi’s support on this project!”
Associate Director
Major Medical Device Company
“Excellent work! Alkemi was prepared with the details, holistic with the assessments, and strategic in the approach. I would not hesitate to use them again.”
Head of Medical Affairs
Rare Disease Immunology Biotech
“Their strategic insights and support were essential – they have a knack for communicating differentiated value.”
Chief Commercial Officer
Rare Degenerative Neuromuscular Biotech
“Just wanted to send an immediate thank you for the excellent training session today. It was very well received by all of us. What an amazing way to (almost) end the week! Thank you again.”
VP Market Access and Reimbursement
Major Medical Technology Company
Get the blueprint for
launching your Breakthrough
info@alkemihealth.com
802-430-4599
Cambridge, MA | Manchester Center, VT | New York, NY
Alkemi LLC © 2025. All rights reserved
Privacy Policy
Get the blueprint for
launching your Breakthrough
info@alkemihealth.com
802-430-4599
Cambridge, MA | Manchester Center, VT | New York, NY
Alkemi LLC © 2025. All rights reserved
Privacy Policy
Get the blueprint for
launching your Breakthrough
info@alkemihealth.com
802-430-4599
Cambridge, MA | Manchester Center, VT | New York, NY
Alkemi LLC © 2025. All rights reserved
Privacy Policy
Get the blueprint for
launching your Breakthrough
info@alkemihealth.com
802-430-4599
Cambridge, MA | Manchester Center, VT | New York, NY
Alkemi LLC © 2025. All rights reserved
Privacy Policy